ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 136515" data-attributes="member: 13851"><p><strong>Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse</strong></p><p></p><p><span style="color: rgb(184, 49, 47)"><strong>Astrid M. H. Horstman, Evelien M. P. Backx, Joey S. J. Smeets, Gabriel N. MarzucaNassr, Janneau van Kranenburg, Douwe de Boer, John Dolmans, Tim Snijders, Lex B. Verdijk, Lisette C. P. G. M. de Groot, Luc J. C. van LoonID*</strong></span></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong>Objective</strong></p><p>To assess whether a single intramuscular injection of nandrolone decanoate prior to immobilization can attenuate the loss of muscle mass and strength in vivo in humans.</p><p></p><p><strong>Design, setting and participants </strong></p><p>Thirty healthy (22±1 years) men were subjected to 7 days of one-legged knee immobilization by means of a full leg cast with (NAD, n = 15) or without (CON, n = 15) prior intramuscular nandrolone decanoate injection (200 mg).</p><p></p><p><strong>Measures</strong></p><p>Before and immediately after immobilization, quadriceps muscle cross-sectional area (CSA) (by means of single-slice computed tomography (CT) scans of the upper leg) and one-legged knee extension strength (one-repetition maximum [1-RM]) were assessed for both legs. Furthermore, muscle biopsies from the immobilized leg were taken before and after immobilization to assess type I and type II muscle fiber cross-sectional area.</p><p></p><p><strong>Results</strong></p><p>Quadriceps muscle CSA decreased during immobilization in both CON and NAD (-6±1% and -6±1%, respectively; main effect of time P<0.01), with no differences between the groups (time×treatment interaction, P = 0.59). Leg muscle strength declined following immobilization (-6±2% in CON and -7±3% in NAD; main effect of time, P<0.05), with no differences between groups (time×treatment interaction, P = 0.55).</p><p></p><p><strong>Conclusions</strong></p><p>This is the first study to report that nandrolone decanoate administration does not preserve skeletal muscle mass and strength during a short period of leg immobilization in vivo in humans.</p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p><strong>Conclusions</strong></p><p></p><p><strong><span style="color: rgb(184, 49, 47)">Administration of a </span><span style="color: rgb(0, 0, 0)">single bolus</span><span style="color: rgb(184, 49, 47)"> of nandrolone decanoate</span><span style="color: rgb(0, 0, 0)"> (200 mg)</span><span style="color: rgb(184, 49, 47)"> prior to a short period of disuse does not attenuate muscle mass or strength loss. </span><span style="color: rgb(0, 0, 0)">This is the </span></strong><span style="color: rgb(0, 0, 0)"><strong>first study to report no preservation of skeletal muscle mass and strength following nandrolone decanoate administration during a short period of leg immobilization in vivo in humans.</strong></span></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p></p><p>They only used a single intramuscular injection of nandrolone decanoate (200 mg).</p></blockquote><p></p>
[QUOTE="madman, post: 136515, member: 13851"] [B]Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse[/B] [COLOR=rgb(184, 49, 47)][B]Astrid M. H. Horstman, Evelien M. P. Backx, Joey S. J. Smeets, Gabriel N. MarzucaNassr, Janneau van Kranenburg, Douwe de Boer, John Dolmans, Tim Snijders, Lex B. Verdijk, Lisette C. P. G. M. de Groot, Luc J. C. van LoonID*[/B][/COLOR] [B]Objective[/B] To assess whether a single intramuscular injection of nandrolone decanoate prior to immobilization can attenuate the loss of muscle mass and strength in vivo in humans. [B]Design, setting and participants [/B] Thirty healthy (22±1 years) men were subjected to 7 days of one-legged knee immobilization by means of a full leg cast with (NAD, n = 15) or without (CON, n = 15) prior intramuscular nandrolone decanoate injection (200 mg). [B]Measures[/B] Before and immediately after immobilization, quadriceps muscle cross-sectional area (CSA) (by means of single-slice computed tomography (CT) scans of the upper leg) and one-legged knee extension strength (one-repetition maximum [1-RM]) were assessed for both legs. Furthermore, muscle biopsies from the immobilized leg were taken before and after immobilization to assess type I and type II muscle fiber cross-sectional area. [B]Results[/B] Quadriceps muscle CSA decreased during immobilization in both CON and NAD (-6±1% and -6±1%, respectively; main effect of time P<0.01), with no differences between the groups (time×treatment interaction, P = 0.59). Leg muscle strength declined following immobilization (-6±2% in CON and -7±3% in NAD; main effect of time, P<0.05), with no differences between groups (time×treatment interaction, P = 0.55). [B]Conclusions[/B] This is the first study to report that nandrolone decanoate administration does not preserve skeletal muscle mass and strength during a short period of leg immobilization in vivo in humans. [B]Conclusions[/B] [B][COLOR=rgb(184, 49, 47)]Administration of a [/COLOR][COLOR=rgb(0, 0, 0)]single bolus[/COLOR][COLOR=rgb(184, 49, 47)] of nandrolone decanoate[/COLOR][COLOR=rgb(0, 0, 0)] (200 mg)[/COLOR][COLOR=rgb(184, 49, 47)] prior to a short period of disuse does not attenuate muscle mass or strength loss. [/COLOR][COLOR=rgb(0, 0, 0)]This is the [/COLOR][/B][COLOR=rgb(0, 0, 0)][B]first study to report no preservation of skeletal muscle mass and strength following nandrolone decanoate administration during a short period of leg immobilization in vivo in humans.[/B][/COLOR] They only used a single intramuscular injection of nandrolone decanoate (200 mg). [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
Nandrolone decanoate administration does not attenuate muscle atrophy during a short period of disuse
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top